These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29422022)

  • 1. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.
    Quintero J; Ramos-Quiroga JA; Sebastián JS; Montañés F; Fernández-Jaén A; Martínez-Raga J; Giral MG; Graell M; Mardomingo MJ; Soutullo C; Eiris J; Téllez M; Pamias M; Correas J; Sabaté J; García-Orti L; Alda JA
    BMC Psychiatry; 2018 Feb; 18(1):40. PubMed ID: 29422022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P
    J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Caregiver Perspective on Paediatric ADHD (CAPPA) survey: Understanding sociodemographic and clinical characteristics, treatment use and impact of ADHD in Europe.
    Flood E; Gajria K; Sikirica V; Dietrich CN; Romero B; Harpin V; Banaschewski T; Quintero J; Erder MH; Fridman M; Chen K
    J Affect Disord; 2016 Aug; 200():222-34. PubMed ID: 27137089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).
    Hakkaart-van Roijen L; Zwirs BW; Bouwmans C; Tan SS; Schulpen TW; Vlasveld L; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):316-26. PubMed ID: 17483870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.
    Burd L; Klug MG; Coumbe MJ; Kerbeshian J
    J Child Neurol; 2003 Aug; 18(8):555-61. PubMed ID: 13677583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    J Pediatr Psychol; 2007 Jul; 32(6):711-27. PubMed ID: 17556402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Cloutier M; Guérin A; Lefebvre P
    J Manag Care Spec Pharm; 2022 Feb; 28(2):168-179. PubMed ID: 34806909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD)].
    Schöffski O; Sohn S; Happich M
    Gesundheitswesen; 2008 Jul; 70(7):398-403. PubMed ID: 18729028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic implications of attention-deficit hyperactivity disorder for healthcare systems.
    Leibson CL; Long KH
    Pharmacoeconomics; 2003; 21(17):1239-62. PubMed ID: 14986737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.
    Lachaine J; De G; Sikirica V; Van Stralen J; Hodgkins P; Yang H; Heroux J; Ben Amor L
    Can J Psychiatry; 2014 Nov; 59(11):597-608. PubMed ID: 25565476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family Burden of Raising a Child with ADHD.
    Zhao X; Page TF; Altszuler AR; Pelham WE; Kipp H; Gnagy EM; Coxe S; Schatz NK; Merrill BM; Macphee FL; Pelham WE
    J Abnorm Child Psychol; 2019 Aug; 47(8):1327-1338. PubMed ID: 30796648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
    Lachaine J; Sikirica V; Mathurin K
    BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Centered Medical Home and Family Burden in Attention-Deficit Hyperactivity Disorder.
    Ronis SD; Baldwin CD; Blumkin A; Kuhlthau K; Szilagyi PG
    J Dev Behav Pediatr; 2015; 36(6):417-25. PubMed ID: 26035140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder.
    Telford C; Green C; Logan S; Langley K; Thapar A; Ford T
    Soc Psychiatry Psychiatr Epidemiol; 2013 Feb; 48(2):337-44. PubMed ID: 22699685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of probable Attention-Deficit/Hyperactivity Disorder symptoms: result from a Spanish sample of children.
    Cerrillo-Urbina AJ; García-Hermoso A; Martínez-Vizcaíno V; Pardo-Guijarro MJ; Ruiz-Hermosa A; Sánchez-López M
    BMC Pediatr; 2018 Mar; 18(1):111. PubMed ID: 29544457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark.
    Jennum P; Hastrup LH; Ibsen R; Kjellberg J; Simonsen E
    Eur Neuropsychopharmacol; 2020 Aug; 37():29-38. PubMed ID: 32682821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium.
    De Ridder A; De Graeve D
    Clin Drug Investig; 2006; 26(2):75-90. PubMed ID: 17163238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.